This conference explores the biomedical relevance of innovative engineering approaches, such as 3D bioprinting, synthetic gene networks, programmable biomaterials, and microfluidic systems, for controlling human organoid organization at multiple scales. These approaches hold tremendous potential for developing novel preclinical drug testing models, disease models, and tissues for regenerative medicine applications, while also advancing our understanding of basic human biology.

This meeting will explore the latest emerging methods in organoid bioengineering, as well as their applications and utility for advancing scientific discovery and medical practice.  It fills a unique need in the scientific community not fulfilled by other conferences, as it focuses on the intersection of organoid biology and engineering with clinical insights. The program will address critical gaps in knowledge by bringing together scientists across disciplines to challenge current research paradigms and employ transformative approaches and methods. The goal is to consolidate the field, move it forward, and bridge it with other areas of disease relevance to enable the greatest impact to science and medicine. The anticipated outcomes include new scientific knowledge, collaborations, changes in clinical practice, and training, with attendees taking away valuable insights on advancing the field using innovative engineering approaches and translational applications.

This conference will be co-located with the Keystone Symposium on Single Cell Biology: Unique Cells to Tissue Ecosystems to enable cross-disciplinary insights and collaborations towards understanding the complex cellular ecosystem that makes up tissues and model organoids.

In the video below, Dr. Quinton Smith from the University of California, Irvine, talks about what to expect from this meeting and why you should attend: